Achieve Life Sciences (NASDAQ: ACHV) — Company Overview, News & Financial Data
Achieve Life Sciences develops therapies for smoking cessation, focusing on innovative solutions to combat nicotine addiction.
Achieve Life Sciences
Achieve Life Sciences (NASDAQ:ACHV) is focused on the development and commercialization of therapies for smoking cessation and nicotine addiction. Its primary project revolves around Cytisinicline, a plant-based alkaloid with the potential to help people quit smoking. By aiming to address the global smoking health epidemic, Achieve Life Sciences is committed to improving overall health outcomes and reducing the burden of smoking-related diseases. Their objective is to provide effective, accessible treatment options that support individuals in their journey to quit smoking and combat nicotine dependence. Through their research and development efforts, Achieve Life Sciences strives to bring innovative solutions to the market, demonstrating their dedication to public health and wellness.
Snapshot
Operations
Products and/or services of Achieve Life Sciences
- Cytisinicline, a smoking cessation aid targeting nicotine addiction.
- Collaborations with academic and research institutions to develop and enhance smoking cessation methods.
- Partnerships for the global commercialization of cytisinicline.
- Research on cytisinicline's effectiveness compared to other smoking cessation aids.
- Development of new formulations and delivery methods for cytisinicline.
- Initiatives to increase awareness and accessibility of smoking cessation solutions.
Achieve Life Sciences executive team
- Erik AtkissonChief Legal Officer
- Andrew D. GoldbergCEO, President & Director
- Benjamin HalladayChief Financial Officer
- Jerry WanVP of Finance & Principal Accounting Officer
- Kaitlyn TusonSenior Vice President of Marketing & Communications
- Mark L. RubinsteinChief Medical Officer
- Mark ZappiaSenior Vice President of Commercial
- Ronald DadinoSenior Vice President of Chemistry, Manufacturing & Controls and Supply Chain
- Gloria CosgroveSenior Vice President of Global Quality
- Nicole P. JonesVice President of Strategic Communications & Stakeholder Relations
Latest news about Achieve Life Sciences
Key financials
Reported results for Achieve Life Sciences, in USD.
- Market cap
- 693.9M
- Revenue (TTM)
- 0
- P/E ratio
- —
- EPS (diluted, TTM)
- -1.7
- Dividend yield
- —
- Profit margin
- 0.0%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 0 | -54.9M | -54.6M | |
| 0 | -39.1M | -39.8M | |
| 0 | -27.3M | -29.8M | |
| 0 | -40.8M | -41.9M |